K201114

Substantially Equivalent

Bidop 7

Applicant: Koven Technology, Inc.
Product code: DPW
Advisory panel: Cardiovascular
Date received: 2020-04-27
Decision date: 2021-01-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Louis, MO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.